The Scientist - Home

Circulating tumor cells allow researchers to detect cancer early, provide an accurate prognosis, monitor progression, and inform personalized medicine.

Making blood in the lab can be hard because scientists don’t know what triggers a key final step in red blood cell maturation. A new study may change that.

Investigating autophagy deficits in the amygdala, this postdoc explores new therapeutic strategies for treating chronic pain.

Emotional or rewarding experiences can preserve memories of concurrent ordinary events, offering insights into how the brain decides what to keep and what to forget.

Years before people develop rheumatoid arthritis, their blood teems with activated immune cells that could serve as biomarkers for early diagnosis.

For the first time, scientists sequenced Robertsonian chromosomes, which can cause Down syndrome and cancer.

Purkinje cells, the neurons of the cerebellum, appear to die in an organized pattern, overturning previous beliefs that neurodegeneration occurs homogenously.

Researchers developed a new AI tool for the preliminary identification of questionable journals that exploit the open-access system.

From CASP to the Virtual Cell Challenge, researchers are leveraging science competitions and high-risk, high-reward grants to drive their fields forward.

A student-led experiment compares bacterial protein synthesis on Earth and in the ISS under microgravity conditions.

Working unconventional hours disrupts the body’s internal clock, which in turn affects the immune system and increases people’s susceptibility to disease.

Will this year’s Nobel Prizes go to GLP-1 research, optogenetics, or something else? Researchers picked their favorites to win the prize.